{"id":118092,"date":"2025-06-11T10:31:18","date_gmt":"2025-06-11T17:31:18","guid":{"rendered":"https:\/\/ixcellsbiotech.com\/?p=118092"},"modified":"2025-12-23T09:04:31","modified_gmt":"2025-12-23T17:04:31","slug":"ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models","status":"publish","type":"post","link":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/","title":{"rendered":"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"iPSCore\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

iXCells Biotechnologies Launches iPSCoreTM Platform <\/b>for Generating Highly Characterized \niPSC-derived Human Cell Models\n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

iXCells Biotechnologies focuses on creating a broad portfolio of iPSC-derived off-the-shelf and custom cell models from healthy and patient donors to make \u201cclinical-trials-in-a-plate” a reality.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

iXCells Biotechnologies USA, Inc.<\/strong> (\u201ciXCells\u201d), a leading cell technology company specializing in the generation of predictive human disease models is pleased to announce the launch of its modular iPSCoreTM<\/sup> platform.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

iXCells\u2019 mission is to empower life science researchers and patient foundations to advance personalized therapies and accelerate discovery of better medicines for a healthier future.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

iXCells\u2019 cell engineering platform iPSCore\u2122<\/i>\u00a0is a unified and dedicated system where tools, skills, experiences and expertise are structured together to design, develop and build iPSC-derived cell products from ethically sourced biospecimens, and cell fractions or cells (e.g. PBMCs or fibroblasts) derived from healthy or patient donors. Cells can be reprogrammed, edited and differentiated into a wide variety of iPSC-derived cell types and 3-dimensional human cell models. iPSCore\u2122<\/i>\u00a0incorporates extensive characterization, descriptively and functionally, which can be used in an assortment of downstream assays tailored to customer needs. Currently the platform processes >1,000 samples per year with routinely >96% success rate and is expected to multiply the output of patient-derived iPSC-derived cells by 2026.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Partnering Opportunities<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u201cNumerous conversations with our clients reveal that relevant human cell models are not readily available, often requiring lengthy design and engineering processes essential for creating the desired genotype and\/or phenotype from demographically defined cohorts,\u201d stated Steve Smith, Chief Commercial Officer. He continued, \u201cOur iPSCore\u2122 platform leverages our capabilities, long-term expertise and passion in cell engineering, enabling iXCells to generate hundreds of iPSC lines and differentiating them into numerous cell types that are characterized for confidence and ultimately provide our customers with access as either off-the-shelf items or tailored made-to-order cells.”

Such iPSC-derived disease models continue to support the pharmaceutical and biotechnology industry\u2019s shift away from animal models as recognized by FDA Modernization Act 2.0 which allows drug developers to submit non-animal data to demonstrate safety and efficacy of investigational drugs prior to conducting clinical trials. Human cell models and specifically patient-derived cell models have shown to be more predictable than animal models and can help find solutions for significant unmet medical needs faster.\u201d

Helge Bastian, PhD, CEO of iXCells expressed his enthusiasm by saying, \u201cThe development and launch of our iPSCore\u2122 platform marks a significant milestone in our company\u2019s history and demonstrates our commitment to unfold the huge potential of one of the most disruptive innovations in the life sciences for developing novel medicines and therapies. Game-changing iPSC-technology combined with continued advancements in subsequent processes to edit and differentiate iPSCs into essentially any cell type of the human body together with steady elevations to characterize the true biological state of such cells will enable researchers to build highly predictive in-vitro cell or microtissue models mimicking human biology as closely as ever seen before.\u201d Dr. Bastian added, \u201cThe integration of these serial technology advancements into an optimized and standardized workflow will allow screening drugs on an endless variety of human genotypes in-vitro. Leveraging this capability in combination with AI technology to identify disease-relevant patterns and phenotypes is paving the way for making the concept of ‘clinical-trials-in-a-plate’ a reality.\u201d<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Partnering Opportunities<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Contact iXCells and build strategic partnerships to accelerate patient-specific drug and therapy developments.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

About iXCells Biotechnologies<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

iXCells Biotechnologies (\u201ciXCells\u201d) is a leading San Diego, California-based cell technology company focused on generating a wide variety of predictive human disease models. In addition, iXCells is pursuing custom and patient-specific services leveraging its expertise in the preparation, handling, engineering and differentiation of induced pluripotent stem cells (iPSCs) and in the isolation of primary cells along with associated services for descriptive and functional cell characterization, compound screening and toxicology testing.<\/p>

The company\u2019s mission is to supply a diverse range of human disease models, derived from ethically sourced patient and healthy donor tissues, to support academic, pharmaceutical, and clinical researchers globally. By providing predictive human cell models, we aim to deepen the understanding of the molecular mechanisms underlying disease onset and progression as much as slow-down or reversion of disease, and accelerate the discovery and development of new medicines and innovative therapies to further advance precision medicine.<\/p>

Contacts<\/strong><\/p>

To request more information visit ixcellsbiotech.com\/ipscore-lp\/<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
COMPANY NEWS<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t<\/i>\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tiXCells Biotechnologies Launches iPSCore Platform for Generating Highly Characterized iPSC-derived Human Cell Models\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tCONTACT US TODAY<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d<\/p>\n","protected":false},"author":234903467,"featured_media":117977,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"_acf_changed":false,"content-type":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_wpcom_ai_launchpad_first_post":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\n{url}","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":false},"categories":[1889,2172],"tags":[],"news_type":[2168,2171],"news_areas":[],"class_list":["post-118092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-product-news","news_type-company-news","news_type-product-news"],"acf":[],"yoast_head":"\niXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models - iXCells<\/title>\n<meta name=\"description\" content=\"iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models - iXCells\" \/>\n<meta property=\"og:description\" content=\"iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/\" \/>\n<meta property=\"og:site_name\" content=\"iXCells\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-11T17:31:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-23T17:04:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"728\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Tom Faulkner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@iXCells\" \/>\n<meta name=\"twitter:site\" content=\"@iXCells\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tom Faulkner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/\"},\"author\":{\"name\":\"Tom Faulkner\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/person\\\/5de2572b7775a5dad73cdc1da275cfe4\"},\"headline\":\"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models\",\"datePublished\":\"2025-06-11T17:31:18+00:00\",\"dateModified\":\"2025-12-23T17:04:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/\"},\"wordCount\":743,\"publisher\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png\",\"articleSection\":[\"Company News\",\"Product News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/\",\"name\":\"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models - iXCells\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png\",\"datePublished\":\"2025-06-11T17:31:18+00:00\",\"dateModified\":\"2025-12-23T17:04:31+00:00\",\"description\":\"iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png\",\"contentUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png\",\"width\":1800,\"height\":728},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ixcellsbiotech.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#website\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/\",\"name\":\"iXCells Biotechnologies\",\"description\":\"Human Relevant Cell Model Expert | iPSC | Primary Cells\",\"publisher\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ixcellsbiotech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#organization\",\"name\":\"iXCells Biotechnologies USA, Inc.\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Logo.png\",\"contentUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Logo.png\",\"width\":256,\"height\":64,\"caption\":\"iXCells Biotechnologies USA, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/iXCells\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ixcells-biotechnologies\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/person\\\/5de2572b7775a5dad73cdc1da275cfe4\",\"name\":\"Tom Faulkner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7c1757209491e07c143af4c5449426c0a2e5362a8d2c2d7e874c17cd9a17264b?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7c1757209491e07c143af4c5449426c0a2e5362a8d2c2d7e874c17cd9a17264b?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7c1757209491e07c143af4c5449426c0a2e5362a8d2c2d7e874c17cd9a17264b?s=96&d=identicon&r=g\",\"caption\":\"Tom Faulkner\"},\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/author\\\/tfaulkner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models - iXCells","description":"iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/","og_locale":"en_US","og_type":"article","og_title":"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models - iXCells","og_description":"iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d","og_url":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/","og_site_name":"iXCells","article_published_time":"2025-06-11T17:31:18+00:00","article_modified_time":"2025-12-23T17:04:31+00:00","og_image":[{"width":1800,"height":728,"url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png","type":"image\/png"}],"author":"Tom Faulkner","twitter_card":"summary_large_image","twitter_creator":"@iXCells","twitter_site":"@iXCells","twitter_misc":{"Written by":"Tom Faulkner","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#article","isPartOf":{"@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/"},"author":{"name":"Tom Faulkner","@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/person\/5de2572b7775a5dad73cdc1da275cfe4"},"headline":"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models","datePublished":"2025-06-11T17:31:18+00:00","dateModified":"2025-12-23T17:04:31+00:00","mainEntityOfPage":{"@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/"},"wordCount":743,"publisher":{"@id":"https:\/\/ixcellsbiotech.com\/#organization"},"image":{"@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#primaryimage"},"thumbnailUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png","articleSection":["Company News","Product News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/","url":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/","name":"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models - iXCells","isPartOf":{"@id":"https:\/\/ixcellsbiotech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#primaryimage"},"image":{"@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#primaryimage"},"thumbnailUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png","datePublished":"2025-06-11T17:31:18+00:00","dateModified":"2025-12-23T17:04:31+00:00","description":"iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d","breadcrumb":{"@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#primaryimage","url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png","contentUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png","width":1800,"height":728},{"@type":"BreadcrumbList","@id":"https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-launches-ipscore-platform-for-generating-highly-characterized-ipsc-derived-human-cell-models\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ixcellsbiotech.com\/"},{"@type":"ListItem","position":2,"name":"iXCells Biotechnologies Launches iPSCore\u2122 Platform for Generating Highly Characterized iPSC-derived Human Cell Models"}]},{"@type":"WebSite","@id":"https:\/\/ixcellsbiotech.com\/#website","url":"https:\/\/ixcellsbiotech.com\/","name":"iXCells Biotechnologies","description":"Human Relevant Cell Model Expert | iPSC | Primary Cells","publisher":{"@id":"https:\/\/ixcellsbiotech.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ixcellsbiotech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ixcellsbiotech.com\/#organization","name":"iXCells Biotechnologies USA, Inc.","url":"https:\/\/ixcellsbiotech.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/logo\/image\/","url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2023\/06\/Logo.png","contentUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2023\/06\/Logo.png","width":256,"height":64,"caption":"iXCells Biotechnologies USA, Inc."},"image":{"@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/iXCells","https:\/\/www.linkedin.com\/company\/ixcells-biotechnologies"]},{"@type":"Person","@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/person\/5de2572b7775a5dad73cdc1da275cfe4","name":"Tom Faulkner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7c1757209491e07c143af4c5449426c0a2e5362a8d2c2d7e874c17cd9a17264b?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7c1757209491e07c143af4c5449426c0a2e5362a8d2c2d7e874c17cd9a17264b?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7c1757209491e07c143af4c5449426c0a2e5362a8d2c2d7e874c17cd9a17264b?s=96&d=identicon&r=g","caption":"Tom Faulkner"},"url":"https:\/\/ixcellsbiotech.com\/author\/tfaulkner\/"}]}},"jetpack_publicize_connections":[],"jetpack_shortlink":"https:\/\/wp.me\/peN4gs-uII","jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2025\/06\/iPSCore-Rounded-PR-Hero-Image-V05-1800px-728px.png","_links":{"self":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts\/118092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/users\/234903467"}],"replies":[{"embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/comments?post=118092"}],"version-history":[{"count":15,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts\/118092\/revisions"}],"predecessor-version":[{"id":118214,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts\/118092\/revisions\/118214"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/media\/117977"}],"wp:attachment":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/media?parent=118092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/categories?post=118092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/tags?post=118092"},{"taxonomy":"news_type","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/news_type?post=118092"},{"taxonomy":"news_areas","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/news_areas?post=118092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}